Alimera Sciences Inc (ALIM)
3.34
-0.29
(-7.99%)
USD |
NASDAQ |
Apr 25, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Alimera Sciences Price to Book Value: 3.787 for April 25, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.116 |
| April 23, 2024 | 4.071 |
| April 22, 2024 | 4.014 |
| April 19, 2024 | 3.787 |
| April 18, 2024 | 3.901 |
| April 17, 2024 | 4.026 |
| April 16, 2024 | 4.060 |
| April 15, 2024 | 4.014 |
| April 12, 2024 | 3.992 |
| April 11, 2024 | 4.366 |
| April 10, 2024 | 4.252 |
| April 09, 2024 | 4.309 |
| April 08, 2024 | 4.286 |
| April 05, 2024 | 4.366 |
| April 04, 2024 | 4.422 |
| April 03, 2024 | 4.479 |
| April 02, 2024 | 4.479 |
| April 01, 2024 | 4.366 |
| March 28, 2024 | 4.422 |
| March 27, 2024 | 4.422 |
| March 26, 2024 | 4.388 |
| March 25, 2024 | 4.524 |
| March 22, 2024 | 4.513 |
| March 21, 2024 | 4.558 |
| March 20, 2024 | 4.411 |
| Date | Value |
|---|---|
| March 19, 2024 | 4.592 |
| March 18, 2024 | 4.536 |
| March 15, 2024 | 4.774 |
| March 14, 2024 | 4.513 |
| March 13, 2024 | 4.332 |
| March 12, 2024 | 4.343 |
| March 11, 2024 | 4.275 |
| March 08, 2024 | 4.502 |
| March 07, 2024 | 4.422 |
| March 06, 2024 | 4.388 |
| March 05, 2024 | 4.286 |
| March 04, 2024 | 4.218 |
| March 01, 2024 | 4.207 |
| February 29, 2024 | 4.014 |
| February 28, 2024 | 3.787 |
| February 27, 2024 | 3.969 |
| February 26, 2024 | 3.833 |
| February 23, 2024 | 3.821 |
| February 22, 2024 | 3.753 |
| February 21, 2024 | 3.685 |
| February 20, 2024 | 3.855 |
| February 16, 2024 | 3.878 |
| February 15, 2024 | 3.855 |
| February 14, 2024 | 3.787 |
| February 13, 2024 | 4.286 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.823
Minimum
Oct 13 2023
4.774
Maximum
Mar 15 2024
3.991
Average
4.057
Median
Dec 13 2023
Price to Book Value Benchmarks
| Eli Lilly and Co | 63.99 |
| NovaBay Pharmaceuticals Inc | 1.706 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6402 |
| Theriva Biologics Inc | 0.1902 |
Price to Book Value Related Metrics
| PS Ratio | 1.030 |
| Price | 3.34 |
| Earnings Yield | -64.74% |
| Market Cap | 174.86M |